Osteoclasts in the Inflammatory Arthritis: Implications for Pathologic Osteolysis

키워드

참고문헌 (72)

1. Schett G, "Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment", Nat Rev Rheumatol, 8, pp.656~664 (2012)
2. Ødegård S, "Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients", Arthritis Rheum, 54, pp.68~75 (2006)
3. Udagawa N, "Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells", Proc Natl Acad Sci U S A, 87, pp.7260~7264 (1990)
4. Rivollier A, "Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment", Blood, 104, pp.4029~4037 (2004)
5. Bugatti S, "Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment", Arthritis Rheum, 52, pp.3448~3459 (2005)
6. Molenaar ET, "Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission", Arthritis Rheum, 50, pp.36~42 (2004)
7. Jones DH, "Role of RANKL and RANK in bone loss and arthritis", Ann Rheum Dis, 61(Suppl 2), pp.ii32~ii39 (2002)
8. Nakashima T, "Evidence for osteocyte regulation of bone homeostasis through RANKL expression", Nat Med, 17, pp.1231~1234 (2011)
9. Xiong J, "Matrix-embedded cells control osteoclast formation", Nat Med, 17, pp.1235~1241 (2011)
10. Meednu N, "Production of RANKL by memory B cells: a link between B cells and bone erosion in rheumatoid arthritis", Arthritis Rheumatol, 68, pp.805~816 (2016)
11. Sato K, "Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction", J Exp Med, 203, pp.2673~2682 (2006)
12. Davidson MG, "Th17 cells induce Th1-polarizing monocyte-derived dendritic cells", J Immunol, 191, pp.1175~1187 (2013)
13. Hashizume M, "IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17", Rheumatology (Oxford), 47, pp.1635~1640 (2008)
14. Boumans MJ, "Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis", Ann Rheum Dis, 71, pp.108~113 (2012)
15. Wheater G, "Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis", Osteoporos Int, 22, pp.3067~3072 (2011)
16. Danks L, "RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation", Ann Rheum Dis, 75, pp.1187~1195 (2016)
17. Takayanagi H, "Osteoimmunology and the effects of the immune system on bone", Nat Rev Rheumatol, 5, pp.667~676 (2009)
18. Koga T, "Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis", Nature, 428, pp.758~763 (2004)
19. Herman S, "Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis", Arthritis Rheum, 58, pp.3041~3050 (2008)
20. Crotti TN, "The immunoreceptor tyrosine-based activation motif (ITAM)-related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints", Arthritis Res Ther, 14, pp.R245~ (2012)
21. Barrow AD, "OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice", J Clin Invest, 121, pp.3505~3516 (2011)
22. Schultz HS, "OSCAR-collagen signaling in monocytes plays a proinflammatory role and may contribute to the pathogenesis of rheumatoid arthritis", Eur J Immunol, 46, pp.952~963 (2016)
23. Schultz HS, "Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor", J Immunol, 194, pp.3169~3179 (2015)
24. Braun T, "Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis", Arthritis Res Ther, 13, pp.235~ (2011)
25. Lam J, "TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand", J Clin Invest, 106, pp.1481~1488 (2000)
26. Zhao B, "TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J", J Exp Med, 209, pp.319~334 (2012)
27. Kobayashi K, "Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF", RANKL-RANK interaction, 2000, pp.191, 275~286
28. Wong BR, "TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells", J Biol Chem, pp.25190~25194 (1997)
29. Anderson DM, "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function", Nature, 390, pp.175~179 (1997)
30. O'Brien W, "RANK-independent osteoclast formation and bone erosion in inflammatory arthritis", Arthritis Rheumatol, 68, pp.2889~2900 (2016)
31. Kim JH, "The mechanism of osteoclast differentiation induced by IL-1", J Immunol, 183, pp.1862~1870 (2009)
32. Axmann R, "Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo", Arthritis Rheum, 60, pp.2747~2756 (2009)
33. Santiago MB, "Jaccoud arthropathy in systemic lupus erythematosus: analysis of clinical characteristics and review of the literature", Medicine (Baltimore), 87, pp.37~44 (2008)
34. Brennan FM, "Evidence that cytokines play a role in rheumatoid arthritis", J Clin Invest, 118, pp.3537~3545 (2008)
35. Arbuckle MR, "Development of autoantibodies before the clinical onset of systemic lupus erythematosus", N Engl J Med, 349, pp.1526~1533 (2003)
36. Takayanagi H, "T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ", Nature, 408, pp.600~605 (2000)
37. Pang M, "RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells", Biochem Biophys Res Commun, 328, pp.756~763 (2005)
38. Abu-Amer Y, "IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB", J Clin Invest, 107, pp.1375~1385 (2001)
39. Bendixen AC, "IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1", Proc Natl Acad Sci U S A, 98, pp.2443~2448 (2001)
40. Kim KW, "Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis", Am J Pathol, 185, pp.3011~3024 (2015)
41. Kotake S, "IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis", J Clin Invest, 103, pp.1345~1352 (1999)
42. Zwerina K, "Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance", Eur J Immunol, 42, pp.413~423 (2012)
43. Zaiss MM, "Treg cells suppress osteoclast formation: a new link between the immune system and bone", Arthritis Rheum, 56, pp.4104~4112 (2007)
44. Zaiss MM, "Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation", Arthritis Rheum, 62, pp.2328~2338 (2010)
45. Axmann R, "CTLA-4 directly inhibits osteoclast formation", Ann Rheum Dis, 67, pp.1603~1609 (2008)
46. van Venrooij WJ, "Citrullination: a small change for a protein with great consequences for rheumatoid arthritis", Arthritis Res, 2, pp.249~251 (2000)
47. Stenberg P, "Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease", Eur J Intern Med, 20, pp.749~755 (2009)
48. James EA, "Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling", Mol Immunol, 45, pp.2651~2659 (2008)
49. Koning F, "Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens", Nat Rev Rheumatol, 11, pp.450~461 (2015)
50. Scally SW, "A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis", J Exp Med, 210, pp.2569~2582 (2013)
51. Catrina AI, "Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis", Nat Rev Rheumatol, 10, pp.645~653 (2014)
52. Holers VM, "Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction", Nat Rev Rheumatol, 14, pp.542~557 (2018)
53. Smolen JS, "Rheumatoid arthritis", Nat Rev Dis Primers, 4, pp.18001~ (2018)
54. Harre U, "Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin", J Clin Invest, 122, pp.1791~1802 (2012)
55. Krishnamurthy A, "Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss", Ann Rheum Dis, 75, pp.721~729 (2016)
56. Kleyer A, "Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies", Ann Rheum Dis, 73, pp.854~860 (2014)
57. Faloni AP, "Structural and functional changes in the alveolar bone osteoclasts of estrogen-treated rats", J Anat, 220, pp.77~85 (2012)
58. Wigerblad G, "Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism", Ann Rheum Dis, 75, pp.730~738 (2016)
59. Brinkmann V, "Neutrophil extracellular traps: is immunity the second function of chromatin", J Cell Biol, 198, pp.773~783 (2012)
60. Khandpur R, "NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis", Sci Transl Med, 5(178), pp.40~ (2013)
61. So AK, "Inflammation in gout: mechanisms and therapeutic targets", Nat Rev Rheumatol, 13, pp.639~647 (2017)
62. Major TJ, "An update on the genetics of hyperuricaemia and gout", Nat Rev Rheumatol, 14, pp.341~353 (2018)
63. Choe JY, "Monosodium urate in the presence of RANKL promotes osteoclast formation through activation of c-Jun N-terminal kinase", Mediators Inflamm, 2015, pp.597512~ (2015)
64. Wang C, "Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation", Cell Death Dis, 7, pp.e2153~ (2016)
65. Robaszkiewicz A, "ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-κB-dependent transcription of IL-1β", Sci Rep, 6, pp.21131~ (2016)
66. Qu C, "NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanisms", FASEB J, 29, pp.1269~1279 (2015)
67. Takami M, "Stimulation by Toll-like receptors inhibits osteoclast differentiation", J Immunol, 169, pp.1516~1523 (2002)
68. Ji JD, "Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-γ in human osteoclast precursors", J Immunol, 183, pp.7223~7233 (2009)
69. Liu-Bryan R, "Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation", Arthritis Rheum, 52, pp.2936~2946 (2005)
70. Rezaei H, "In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial", Ann Rheum Dis, 71, pp.186~191 (2012)
71. Takeuchi T, "Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial", Ann Rheum Dis, 75, pp.983~990 (2016)
72. Redlich K, "Inflammatory bone loss: pathogenesis and therapeutic intervention", Nat Rev Drug Discov, 11, pp.234~250 (2012)

관련 논문AI추천